TNBC shows a higher proliferation rate and higher incidence of metastases than the other breast cancer subtypes, and the absence of expression of ER, PR, and/or over-expression of HER2, leave chemotherapy the only, often ineffective therapeutic alternative for this neoplasia [1,4]. This evidence concerns the gene ERBB2 and breast cancer.